These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 12383009)

  • 1. Kappa-opioid receptor model in a phospholipid bilayer: molecular dynamics simulation.
    Iadanza M; Höltje M; Ronsisvalle G; Höltje HD
    J Med Chem; 2002 Oct; 45(22):4838-46. PubMed ID: 12383009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elucidation of conformational states, dynamics, and mechanism of binding in human κ-opioid receptor complexes.
    Leonis G; Avramopoulos A; Salmas RE; Durdagi S; Yurtsever M; Papadopoulos MG
    J Chem Inf Model; 2014 Aug; 54(8):2294-308. PubMed ID: 25060329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling of kappa-opioid receptor/agonists interactions using pharmacophore-based and docking simulations.
    Lavecchia A; Greco G; Novellino E; Vittorio F; Ronsisvalle G
    J Med Chem; 2000 Jun; 43(11):2124-34. PubMed ID: 10841791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular simulation of dynorphin A-(1-10) binding to extracellular loop 2 of the kappa-opioid receptor. A model for receptor activation.
    Paterlini G; Portoghese PS; Ferguson DM
    J Med Chem; 1997 Sep; 40(20):3254-62. PubMed ID: 9379445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular modeling on kappa opioid receptor and its interaction with nonpeptide kappa opioid agonists.
    Liu DX; Jiang HL; Shen JS; Zhu WL; Zhao L; Chen KX; Ji RY
    Zhongguo Yao Li Xue Bao; 1999 Feb; 20(2):131-6. PubMed ID: 10437159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformational analysis and automated receptor docking of selective arylacetamide-based kappa-opioid agonists.
    Subramanian G; Paterlini MG; Larson DL; Portoghese PS; Ferguson DM
    J Med Chem; 1998 Nov; 41(24):4777-89. PubMed ID: 9822548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative modeling of human kappa opioid receptor and docking analysis with the peptide YFa.
    Patra MC; Kumar K; Pasha S; Chopra M
    J Mol Graph Model; 2012 Mar; 33():44-51. PubMed ID: 22172315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Building 3D-structural model of kappa opioid receptor and studying its interaction mechanism with dynorphin A(1-8).
    Wan XH; Huang XQ; Zhou DH; Jiang HL; Chen KX; Chi ZQ
    Acta Pharmacol Sin; 2000 Aug; 21(8):701-8. PubMed ID: 11501178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New benzomorphan derivatives of MPCB as MOP and KOP receptor ligands.
    Pasquinucci L; Iadanza M; Marrazzo A; Prezzavento O; Ronsisvalle S; Scoto GM; Parenti C; De Luca L; Ronsisvalle G
    Pharmazie; 2007 Nov; 62(11):813-24. PubMed ID: 18065096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid receptor three-dimensional structures from distance geometry calculations with hydrogen bonding constraints.
    Pogozheva ID; Lomize AL; Mosberg HI
    Biophys J; 1998 Aug; 75(2):612-34. PubMed ID: 9675164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of extracellular loop II of κ-opioid receptor (196-228) with opioid peptide dynorphin in membrane environments as revealed by solid state nuclear magnetic resonance, quartz crystal microbalance and molecular dynamics simulation.
    Kira A; Javkhlantugs N; Miyamori T; Sasaki Y; Eguchi M; Kawamura I; Ueda K; Naito A
    J Phys Chem B; 2014 Aug; 118(32):9604-12. PubMed ID: 25059685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the transmembrane domain 4/extracellular loop 2 junction of the human gonadotropin-releasing hormone receptor in ligand binding and receptor conformational selection.
    Forfar R; Lu ZL
    J Biol Chem; 2011 Oct; 286(40):34617-26. PubMed ID: 21832286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular docking reveals a novel binding site model for fentanyl at the mu-opioid receptor.
    Subramanian G; Paterlini MG; Portoghese PS; Ferguson DM
    J Med Chem; 2000 Feb; 43(3):381-91. PubMed ID: 10669565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotype-selective modes of action of κ-opioid receptor agonists.
    Vardy E; Mosier PD; Frankowski KJ; Wu H; Katritch V; Westkaemper RB; Aubé J; Stevens RC; Roth BL
    J Biol Chem; 2013 Nov; 288(48):34470-83. PubMed ID: 24121503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular dynamics simulations predict a tilted orientation for the helical region of dynorphin A(1-17) in dimyristoylphosphatidylcholine bilayers.
    Sankararamakrishnan R; Weinstein H
    Biophys J; 2000 Nov; 79(5):2331-44. PubMed ID: 11053113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NMR structure and dynamics of the agonist dynorphin peptide bound to the human kappa opioid receptor.
    O'Connor C; White KL; Doncescu N; Didenko T; Roth BL; Czaplicki G; Stevens RC; Wüthrich K; Milon A
    Proc Natl Acad Sci U S A; 2015 Sep; 112(38):11852-7. PubMed ID: 26372966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NMR and structural model of dynorphin A (1-17) bound to dodecylphosphocholine micelles.
    Tessmer MR; Kallick DA
    Biochemistry; 1997 Feb; 36(8):1971-81. PubMed ID: 9047294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toward a structure-based model of salvinorin A recognition of the kappa-opioid receptor.
    Kane BE; McCurdy CR; Ferguson DM
    J Med Chem; 2008 Mar; 51(6):1824-30. PubMed ID: 18293909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular modeling and molecular dynamics simulation of the human A2B adenosine receptor. The study of the possible binding modes of the A2B receptor antagonists.
    Ivanov AA; Baskin II; Palyulin VA; Piccagli L; Baraldi PG; Zefirov NS
    J Med Chem; 2005 Nov; 48(22):6813-20. PubMed ID: 16250640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-dimensional models of histamine H3 receptor antagonist complexes and their pharmacophore.
    Axe FU; Bembenek SD; Szalma S
    J Mol Graph Model; 2006 May; 24(6):456-64. PubMed ID: 16386444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.